Pharmacoepidemiology and Drug Safety

Published by: John Wiley & Sons  

People

  1. Flory
    Flory
  2. Schrag
    Schrag
  3. Downs-Canner
    Downs-Canner
  4. Gounder
    Gounder
  5. Green
    Green
  6. Makker
    Makker
  7. O'Reilly
    O'Reilly
  8. Panageas
    Panageas
  9. Taur
    Taur
  10. Yu
    Yu

Groups

  1. Department of Medicine (11)
  2. Division of Subspecialty Medicine (6)
  3. Population Sciences Research Program (5)
  4. Center for Pancreatic Cancer Research (4)
  5. Solid Tumor Oncology Division (4)
  6. Dermatology (3)
  7. Endocrinology (2)
  8. Epidemiology and Biostatistics (2)
  9. Gastrointestinal Oncology Service (2)
  10. Biostatistics Service (1)
Search Within
Formats
  1. Meeting Abstract (13)
  2. Journal Article (6)
Groups
  1. Department of Medicine (11)
  2. Division of Subspecialty Medicine (6)
  3. Population Sciences Research Program (5)
  4. Center for Pancreatic Cancer Research (4)
  5. Solid Tumor Oncology Division (4)
  6. Dermatology (3)

More Groups

People
  1. Susan Oliveria (3)
  2. Deborah Schrag (2)
  3. James Flory (2)
  4. Angela Green (1)
  5. Ann Zauber (1)
  6. Antonio Omuro (1)

More People

Years
  1. 2024 (2)
  2. 2023 (2)
  3. 2022 (3)
  4. 2021 (1)
  5. 2020 (2)
  6. 2018 (1)

More Years

Publishers
  1. John Wiley & Sons (19)

Results (19)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • NALIRIFOX versus FOLFOX as first-line treatment of metastatic pancreatic ductal adenocarcinoma (mPDAC): Real-world comparative overall (OS) survival analysis
    Meeting Abstract

    O'Reilly, E.; Li, J.; DerSarkissian, M.; Chang, R.; Cheng, M.; Yu, L.; Rane, D.; Zhang, L.; Xiao, Z.; Benzaghou, F.; more...
    Pharmacoepidemiology and Drug Safety (2024)

    Fulltext@MSK | Save
  • The Oncology QCARD Initiative: Fostering efficient evaluation of initial real-world data proposals
    Journal Article

    Rivera, D. R.; Eckert, J. C.; Rodriguez-Watson, C.; Lerro, C. C.; Bertagnolli, M. M.; Hubbard, R. A.; Kushi, L. H.; Lund, J. L.; Schrag, D.; Wang, S. V.; more...
    Pharmacoepidemiology and Drug Safety (2024)

    Fulltext@MSK | Save
  • Real-world treatment patterns in recurrent or advanced endometrial cancer patients on first-line systemic therapy in the United States
    Meeting Abstract

    Ogando, Y. M.; Chen, L.; Zhang, J.; Kelkar, S. S.; Prabhu, V. S.; Miles, N.; Green, A.; Makker, V.
    Pharmacoepidemiology and Drug Safety (2023)

    Fulltext@MSK | Save
  • Effectiveness research in oncology with electronic health record data: A retrospective cohort study emulating the PALOMA-2 trial
    Journal Article

    Merola, D.; Young, J.; Schrag, D.; Lin, K. J.; Alwardt, S.; Schneeweiss, S.
    Pharmacoepidemiology and Drug Safety (2023)

    Fulltext@MSK | Save
  • Calcium channel blockers used concomitantly with insulin Secretagogues and serious hypoglycemia
    Meeting Abstract

    Nam, Y. H.; Brensinger, C. M.; Bilker, W. B.; Flory, J.; Leonard, C. E.; Hennessy, S.
    Pharmacoepidemiology and Drug Safety (2022)

    Fulltext@MSK | Save
  • Comparing the effects of neoadjuvant versus adjuvant chemotherapy in stage II-III, triple-negative breast cancer: Illustration of trial emulation using the clone-censor-weight method
    Meeting Abstract

    Su, I. H.; Gaber, C.; Downs-Canner, S.; Duchesneau, E.; Lund, J.
    Pharmacoepidemiology and Drug Safety (2022)

    Fulltext@MSK | Save
  • Validation of an international classification of disease (ICD) 10 algorithm for hypoglycemia in administrative claims data
    Meeting Abstract

    Her, Q.; Dejene, S.; Min, J. Y.; Pate, V.; Funk, M. J.; Flory, J.
    Pharmacoepidemiology and Drug Safety (2022)

    Fulltext@MSK | Save
  • Selection matters: Addressing biases in linked clinico-genomic data sets
    Meeting Abstract

    Panageas, K.; Kehl, K. L.; Incerti, D.; Stürmer, T.
    Pharmacoepidemiology and Drug Safety (2021)

    Fulltext@MSK | Save
  • Real-world outcomes of patients with locally advanced or metastatic epithelioid sarcoma
    Meeting Abstract

    Gounder, M. M.; Merriam, P.; Ratan, R.; Patel, S. R.; Chugh, R.; Villalobos, V. M.; Thornton, M.; Van Tine, B. A.; Abdelhamid, A. H.; Joshi, P.; more...
    Pharmacoepidemiology and Drug Safety (2020)

    Fulltext@MSK | Save
  • A US multicenter chart review study of patients with metastatic pancreatic ductal adenocarcinoma receiving liposomal irinotecan after gemcitabine-based therapy
    Meeting Abstract

    Yu, K. H.; Hendifar, A.; Alese, O.; Draper, A.; Abdelrahim, M.; Burns, E.; Khan, G.; Cockrum, P.; Bhak, R.; DerSarkissian, M.; more...
    Pharmacoepidemiology and Drug Safety (2020)

    Fulltext@MSK | Save

    • Pharmacoepidemiology and Drug Safety – authorized name for:

    Name ISSN / ISBN Publisher
    Pharmacoepidemiology and Drug Safety 10538569 John Wiley & Sons
    Pharmacoepidemiology and Drug Safety 10538569 Unknown
    Pharmacoepidemiology and Drug Safety 1053-8569 John Wiley & Sons
    Pharmacoepidemiology and Drug Safety 1053-8569 John Wiley & Sons
    Pharmacoepidemiology and Drug Safety 1053-8569 Wiley Blackwell
    Pharmacoepidemiology and Drug Safety 1053-8569 Wiley Blackwell
    Pharmacoepidemiology and Drug Safety 10538569 John Wiley & Sons
    Pharmacoepidemiology and Drug Safety 10538569 John Wiley & Sons